Please assess the completion status of the following clinical trial:

Trial Title: REVITIVE for the Treatment of Patients With Venous Insufficiency

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ability to understand the study and provide meaningful written informed consent for the study.~* Willing, able, and committed to participate in the procedures for the full length of the study.~* All ethnic groups, male or female above the age of 18 years.~* Diagnosis of chronic venous insufficiency (C2-C5 CEAP classified)~* Be of non-childbearing potential; or using adequate contraception and have a negative urine pregnancy test result within 24 hours if appropriate before using the device.~* Blood pressure currently under moderate control (\<160/100mmHg)~* No current foot ulceration.~Exclusion Criteria:~* Has insufficient ability to understand the subject information sheet, consent form and verbal instruction.~* Has an unstable condition (eg psychiatric disorder, a recent history of substance abuse or otherwise thought to be unreliable or incapable of complying wight he requirements of the clinical investigational plan (CIP).~* Has any metal implants.~* Pregnant.~* Has a cardiac pacemaker, AICD or other implanted electrical device.~* Has an existing DVT.~* Has an acute medical condition other than chronic venous insufficiency.~* Has recent lower limb injury or lower back pain.~* Has current foot ulceration or other skin ulcers.~* Has cardiovascular disease.~* Has foot deformities.~* Has any disorder that, in the opinion of the investigator, might interfere with the conduct of the study.~* Has an ABPI \< 0.8.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- REVITIVE IX: actual device (Type: ACTIVE_COMPARATOR): Trial participants will receive the true Revitive IX device
- REVITIVE IX: sham device (Type: SHAM_COMPARATOR): Trial participants will receive a sham device

Based on this trial design, predict the completion outcome and termination type (if applicable).